Last Update

2016-06-27T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Diane Young?

Dr. Diane C. Young

Vice President of Clinical Development

Novartis Oncology

Direct Phone: (862) ***-****       

Email: d***@***.com

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Novartis Oncology

One Health Plaza, Bldg 337 & A19.3H

East Hanover, New Jersey 07936

United States

Company Description

Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, pr ... more

Find other employees at this company (870)

Background Information

Employment History

Vice President, Global Clinical Development

Johnson & Johnson

Affiliations

Board Member
The Valerie Fund

Education

MD

Web References (197 Total References)


The Valerie Fund Board of Trustees

www.thevaleriefund.org [cached]

Diane Young, M.D. - Novartis

...
Diane Young, M.D.
...
Diane Young, M.D., Novartis Diane is currently the Vice President of Clinical Development at Novartis Oncology. In this position, she leads a global group of clinical research personnel and oversees the development of a diverse pipeline of oncology and hematology products, including targeted therapies, cytotoxic chemotherapy, and iron chelation therapy. She has pursued her career in research in the pharmaceutical industry for eighteen years, with positions of increasing responsibility at Hoffman-La Roche, Sandoz, and Johnson and Johnson, prior to joining Novartis.


Board of Trustees - The Valerie Fund

www.thevaleriefund.org [cached]

Diane Young, M.D., Novartis

...
Diane Young, M.D., Novartis Diane Young is currently the Vice President of Clinical Development at Novartis Oncology. In this position, she oversees the development of a diverse pipeline of oncology and hematology products, including targeted therapies, cytotoxic chemotherapy, iron chelation therapy, and others. She leads a global group of clinical research personnel. She has pursued her career in research in the pharmaceutical industry for eighteen years, with positions of increasing responsibility at Hoffman-La Roche, Sandoz, and Johnson and Johnson, prior to joining Novartis.


Positive results prompt US National Cancer Institute to make Gleevec available to patients in post-surgical GIST study | Gistinfo.org

www.gistinfo.org [cached]

With these new data, we see that Gleevec may help patients with early GIST, said Diane Young, MD, Head of Global Medical Affairs at Novartis Oncology.


Gleevec(R) Approved in the US for Five Rare Life-Threatening Disorders With Limited Treatment Options

www.mpnresearchfoundation.org [cached]

"The effectiveness of Gleevec in these five diseases further underscores how cancers and diseases of different origin and location can share common pathways that often respond to the same targeted treatment," said Diane Young, MD, Vice President and global head of Clinical Development at Novartis Oncology.


Dr. Diane C. Young is the ...

www.memphisdailynews.com [cached]

Dr. Diane C. Young is the new vice president, chief medical officer, of Learn more about GTx Inc

...
Young is an oncologist with 25 years of clinical development experience in the industry, most recently at Novartis, where she spent 12 years in global and regional leadership roles in oncology clinical development and medical affairs. She also spent a decade at Johnson and Johnson, serving as vice president of global development at R.W. Johnson Pharmaceutical Research Institute.
In her new role, Young will help oversee the clinical development of GTx's product candidates, including its selective androgen receptor modulator, enobosarm.

Similar Profiles

Other People with this Name

Other people with the name Young

Janine Young
Diocese of El Paso

Rich Young
Advance Packaging Technologies

Betty Young
Children's Foundation

Bruce Young
St. Mary's Soil Conservation District

Don Young

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory